顺铂
三阴性乳腺癌
细胞周期
调节器
癌症研究
DNA损伤
细胞周期检查点
生物
细胞生长
细胞生物学
信号转导
乳腺癌
细胞培养
细胞
癌症
化学
DNA
遗传学
化疗
基因
作者
Anne Margriet Heijink,Marieke Everts,Megan E. Honeywell,Ryan Richards,Yannick P. Kok,Elisabeth G.E. de Vries,Michael J. Lee,Marcel A.T.M. van Vugt
出处
期刊:Cell Reports
[Cell Press]
日期:2019-08-01
卷期号:28 (9): 2345-2357.e5
被引量:37
标识
DOI:10.1016/j.celrep.2019.07.070
摘要
Triple-negative breast cancers (TNBCs) display great diversity in cisplatin sensitivity that cannot be explained solely by cancer-associated DNA repair defects. Differential activation of the DNA damage response (DDR) to cisplatin has been proposed to underlie the observed differential sensitivity, but it has not been investigated systematically. Systems-level analysis-using quantitative time-resolved signaling data and phenotypic responses, in combination with mathematical modeling-identifies that the activation status of cell-cycle checkpoints determines cisplatin sensitivity in TNBC cell lines. Specifically, inactivation of the cell-cycle checkpoint regulator MK2 or G3BP2 sensitizes cisplatin-resistant TNBC cell lines to cisplatin. Dynamic signaling data of five cell cycle-related signals predicts cisplatin sensitivity of TNBC cell lines. We provide a time-resolved map of cisplatin-induced signaling that uncovers determinants of chemo-sensitivity, underscores the impact of cell-cycle checkpoints on cisplatin sensitivity, and offers starting points to optimize treatment efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI